Status | Study |
RECRUITING |
Study Name: Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study Condition: Primary Sclerosing Cholangitis Date: 2023-06-01 Interventions: Rosuvastatin 20 mg tablet once daily by mouth |
NOT_YET_RECRUITING |
Study Name: CS0159 in Chinese Patients With PSC (Primary Sclerosing Cholangitis) Condition: Date: 2023-05-18 Interventions: Oral QD |
RECRUITING |
Study Name: Detoxification of the Liver In PSC (Dolphin) Condition: Primary Sclerosing Cholangitis Date: 2023-04-18 Interventions: Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will rec |
RECRUITING |
Study Name: A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. Condition: Primary Sclerosing Cholangitis Date: 2022-11-22 Interventions: Oral Tablet |
RECRUITING |
Study Name: Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis. Condition: Primary Sclerosing Cholangitis Date: 2022-03-04 Interventions: Hymecromone 400 mg 3 times daily by mouth. |
RECRUITING |
Study Name: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach Condition: Primary Sclerosing Cholangitis Date: 2020-12-24 |
Recruiting |
Study Name: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-11-22 Interventions: Drug: Curcumin Subjects will receive one 750 mg softgel by mouth twice a day for 12 weeks. Each each 750 |
Recruiting |
Study Name: Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Condition: Primary Sclerosing Cholangitis Date: 2016-06-13 Interventions: Drug: GS-9674 Tablet(s) admini |
Not yet recruiting |
Study Name: A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-05-17 Interventions: Drug: hymecromone hymecromone treatment as described |
Recruiting |
Study Name: Quality of Life in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-03-11 Interventions: Other: quality of life survey subjects with PSC will be administered a survey to assess their quality of |